MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
1.110
0.000
0.00%
Closed 16:00 12/05 EST
OPEN
1.110
PREV CLOSE
1.110
HIGH
1.150
LOW
1.110
VOLUME
18.58K
TURNOVER
--
52 WEEK HIGH
2.550
52 WEEK LOW
0.9841
MARKET CAP
9.85M
P/E (TTM)
-0.7512
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BRTX last week (1124-1128)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 11/28 21:06
Weekly Report: what happened at BRTX last week (1117-1121)?
Weekly Report · 11/24 09:19
BioRestorative Therapies Inc. unveils regenerative medicine pipeline and commercial plans in new investor presentation
Reuters · 11/22 00:29
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/20 17:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/20 12:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 11/19 21:07
BioRestorative Therapies files to sell 508,592 shares of common stock for holder
TipRanks · 11/18 21:50
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.